US Broker Ratings

Amgen Inc. (AMGN) Investor Outlook: Evaluating a Solid Healthcare Player with Limited Upside Potential

Amgen Inc. (NASDAQ: AMGN), a heavyweight in the healthcare sector, stands as a formidable player among drug manufacturers, boasting a substantial market capitalization of $188.01 billion. Headquartered in Thousand Oaks,..

Incyte Corporation (INCY) Stock Analysis: Exploring a Potential 18% Upside in the Biotechnology Sector

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, is currently attracting attention from investors due to its robust growth potential and a promising product pipeline. With a..

BeOne Medicines Ltd. (ONC) Stock Analysis: Unveiling a 44% Potential Upside with Strong Buy Ratings

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is capturing the attention of investors with its robust performance and promising growth trajectory. Based in Basel, Switzerland, this..

Medtronic plc (MDT): Investor Outlook Highlights 27% Potential Upside

Medtronic plc (NYSE: MDT) is a giant in the healthcare sector, specifically within the medical devices industry, with a commanding market capitalization of $111.88 billion. Headquartered in Galway, Ireland, the..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating a 12.4% Upside in a Volatile Market

Molina Healthcare Inc (NYSE: MOH), a key player in the healthcare plans industry, presents an intriguing opportunity for investors despite a recent dip in its stock price. With a market..

Mettler-Toledo International (MTD) Stock Analysis: Potential Upside Amidst Strong Revenue Growth

Mettler-Toledo International Inc. (NYSE: MTD), a leader in precision instruments and services, stands as a significant player in the healthcare sector, specializing in diagnostics and research. With a robust market..

GSK plc (GSK) Stock Analysis: A Healthcare Giant with a 6.76% Potential Upside

For investors seeking opportunities in the healthcare sector, GSK plc (GSK) presents an intriguing proposition. As a prominent player in the drug manufacturing industry with a market capitalization of $108.45..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: A 40% Upside Potential Backed by Strong Buy Ratings

Thermo Fisher Scientific Inc (NYSE: TMO) stands as a formidable player within the healthcare sector, specifically in the diagnostics and research industry. With a robust market capitalization of $175.85 billion,..

IDEXX Laboratories, Inc. (IDXX)

⚠️ No article content returned.

..

Hologic, Inc. (HOLX) Investor Outlook: Navigating Growth in the Medical Instruments Sector

Hologic, Inc. (NASDAQ: HOLX), a leader in the healthcare sector specializing in medical instruments and supplies, presents an intriguing case for investors focused on the intersection of technology and women’s..

HCA Healthcare, Inc. (HCA) Stock Analysis: Evaluating Growth and 15% Upside Potential

HCA Healthcare, Inc. (NYSE: HCA), a stalwart in the healthcare sector, offers investors a compelling opportunity with a market capitalization of $105.52 billion. Despite a recent dip of 0.02%, bringing..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: A 35% Upside Potential Amidst Strong Revenue Growth

Investors eyeing the healthcare sector may find GE HealthCare Technologies Inc. (NYSE: GEHC) an intriguing opportunity. With a substantial market capitalization of $31.59 billion, GE HealthCare operates in the medical..

AbbVie Inc. (ABBV) Stock Analysis: Unveiling a Potential 18.98% Upside Amid Robust Dividend Yield

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, continues to capture investor attention with its promising growth potential and solid dividend yield. With a market capitalization of $370.38..

West Pharmaceutical Services (WST) Stock Analysis: A Healthcare Powerhouse with a 30% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a key player in the healthcare sector, specifically within the medical instruments and supplies industry. With a robust market capitalization of $17.54..

Biogen Inc. (BIIB) Stock Analysis: Exploring a 12% Potential Upside Amidst Market Fluctuations

Biogen Inc. (BIIB), a significant player in the healthcare sector, particularly in the drug manufacturing industry, has been navigating a dynamic market landscape. With a market capitalization of $26.98 billion,..

Veeva Systems Inc. (VEEV) Stock Analysis: A Potential 56.98% Upside Amidst Healthcare Tech Expansion

Veeva Systems Inc. (NYSE: VEEV) stands as a formidable player in the healthcare technology sector, offering a comprehensive suite of cloud-based software solutions tailored to the life sciences industry. With..

CVS Health Corporation (CVS) Stock Analysis: Robust Buy Ratings and a Potential 37.7% Upside Captivate Investors

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, presents a compelling investment opportunity marked by strong analyst endorsements and substantial growth potential. With a market capitalization of..

Regeneron Pharmaceuticals (REGN): Investor Outlook with a Promising 18% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands out in the biotechnology sector with a robust market capitalization of $77.99 billion, reflecting its significant influence and stature in the healthcare industry. As..

Johnson & Johnson (JNJ)

⚠️ No article content returned.

..

Gilead Sciences, Inc. (GILD) Investor Outlook: Exploring a 17.27% Potential Upside

Gilead Sciences, Inc. (NASDAQ: GILD), a stalwart in the healthcare sector, continues to capture investor attention with its robust pipeline and strategic collaborations. With a market capitalization of $166.63 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds